PPCB ▲ +5.9% - Propanc Biopharma, Inc.
$PPCB - Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
16-OCT-2026 08:36 AM ET
Share this post
More filings for $PPCB
PPCB ▲ +2.4% - Propanc Biopharma, Inc.Oct 14, 2026PPCB ▲ +2.0% - Propanc Biopharma, Inc.Oct 7, 2026PPCB ▲ +7.9% - Propanc Biopharma, Inc.Sep 22, 2026PPCB ▼ -1.0% - Propanc Biopharma, Inc.Sep 9, 2026PPCB ▲ +177.6% - Propanc Biopharma, Inc.Aug 27, 2026
View full $PPCB filing history →💬 Comments
Loading comments…
Leave a comment